Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BITX | 18.00 | 0.36 | +2.04% |
| Volatility Shares 2x Bitcoin ETF (BITX) | |||
| GSC | 63.27 | 0.68 | +1.09% |
| Goldman Sachs Small Cap Equity ETF (GSC) | |||
| ENHI | 26.61 | 0.17 | +0.64% |
| iShares Enhanced International Active ETF (ENHI) | |||
| BRIB | 24.46 | 0.03 | +0.12% |
| FIS Bright Portfolios Core Bond ETF (BRIB) | |||
| BBYY | 8.19 | 0.01 | +0.07% |
| GraniteShares YieldBOOST BABA ETF (BBYY) | |||
A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with XRAY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then XRAY could also see price increases.
| Ticker / NAME | Correlation To AXGN | 1D Price Change % | ||
|---|---|---|---|---|
| AXGN | 100% | -1.47% | ||
| XRAY - AXGN | 36% Loosely correlated | +1.41% | ||
| ITGR - AXGN | 31% Poorly correlated | +0.17% | ||
| CLPT - AXGN | 31% Poorly correlated | +7.19% | ||
| GMED - AXGN | 31% Poorly correlated | -1.14% | ||
| ICUI - AXGN | 30% Poorly correlated | -1.66% | ||
More | ||||
| Ticker / NAME | Correlation To AXGN | 1D Price Change % |
|---|---|---|
| AXGN | 100% | -1.47% |
| Health Services category (240 stocks) | 10% Poorly correlated | +0.58% |
| Medical/Nursing Services category (139 stocks) | 9% Poorly correlated | +1.45% |
a provider of products and technologies for peripheral nerve reconstruction and regeneration
Industry MedicalNursingServices
AXGN saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In 73 of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at 86%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AXGN's RSI Oscillator exited the oversold zone, 18 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for AXGN just turned positive on October 20, 2026. Looking at past instances where AXGN's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
Following a +4.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in 271 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
AXGN moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
AXGN broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AXGN entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.705) is normal, around the industry mean (3.837). P/E Ratio (-56.746) is within average values for comparable stocks, (2.078). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). AXGN has a moderately high Dividend Yield (0.105) as compared to the industry average of (0.010). P/S Ratio (8.961) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.